© The American Society of Gene & Cell Therapy

corrigendum

doi:10.1038/mt.2014.16

Corrigendum to “Silencing Mutant ATXN3 Expression Resolves Molecular Phenotypes in SCA3 Transgenic Mice” Edgardo Rodríguez-Lebrón, Maria do Carmo Costa, Katiuska Luna-Cancalon, Therese M Peron, Svetlana Fischer, Ryan L Boudreau, Beverly L Davidson and Henry L Paulson Molecular Therapy (2013) 21: 1909–1918. doi:10.1038/mt.2013.152

Following the publication of this article, the authors noted that the name of Maria do Carmo Costa was incorrectly listed as Maria doCarmo Costa in the author line. The correct author line appears above.

doi:10.1038/mt.2014.20

Corrigendum to “Dual Masking of Specific Negative Splicing Regulatory Elements Resulted in Maximal Exon 7 Inclusion of SMN2 Gene” Peng Wen Pao, Keng Boon Wee, Woon Chee Yee and Zacharias Aloysius Dwi Pramono Molecular Therapy (2014) 22: 854–876. doi:10.1038/mt.2013.276

Following the publication of this article, the authors noted that the name of Zacharias Aloysius Dwi Pramono was incorrectly listed as Zacharias Aloysius DwiPramono in the author line. The correct author line appears above.

Molecular Therapy  vol. 22 no. 4, 891 apr. 2014

891

Corrigendum to "Silencing Mutant ATXN3 Expression Resolves Molecular Phenotypes in SCA3 Transgenic Mice".

Corrigendum to "Silencing Mutant ATXN3 Expression Resolves Molecular Phenotypes in SCA3 Transgenic Mice". - PDF Download Free
356KB Sizes 0 Downloads 9 Views